Cartalax (50mg) About This Product
The Cartalax peptide is a synthetic tripeptide bioregulator composed of the amino acid sequence Ala–Glu–Asp (AED). Laboratories that buy Cartalax peptide or order Cartalax peptide materials reference this compound for controlled laboratory research involving peptide–cell interactions and connective tissue–related experimental models. Cartalax originates from Russian peptide bioregulation research associated with the St. Petersburg Institute of Bioregulation and Gerontology, where short peptides have been studied in tissue-specific cellular systems.
Cartalax is structurally homologous to regions of type XI collagen, a component of connective tissue. This structural similarity underlies its use in laboratory studies involving chondrocytes and fibroblasts. In experimental settings, Cartalax has been examined for direct interaction with nuclear components in cell culture models, without reliance on membrane receptor signaling.
The product is supplied as a lyophilized powder in 50 mg sterile glass vials, commonly verified to ≥98% purity by HPLC, and intended exclusively for controlled laboratory research.
Product Specifications
- Molecular weight: 333.29 g/mol
- Molecular formula: C₁₂H₁₉N₃O₈
- Form: Lyophilized powder
- Vial size: 50 mg sterile glass vial
Cartalax (50mg) Key Features and Benefits
- Chemical identity: Tripeptide (AED) composed of three amino acids
- Purity: Commonly produced at ≥98%, verified by HPLC
- Non-hormonal profile: Evaluated without involvement of endocrine signaling pathways
- Research focus: Studied in laboratory models involving connective tissue cell cultures
- Cellular research scope: Examined in experimental systems related to structural maintenance and cellular stress response
- Format: Supplied as a lyophilized powder for laboratory handling and storage
- Research compatibility: Suitable for controlled in vitro studies alongside other short regulatory peptides
For laboratory research use only.
Cartalax (50mg) Mechanism & Research Applications
Cartalax has been studied in laboratory research as a tissue-associated peptide examined for its interaction with intracellular regulatory processes in cell culture systems. Rather than acting through membrane receptors, it has been evaluated in experimental models examining peptide effects on nuclear and transcriptional activity.
Research applications include:
- Connective tissue cell culture studies involving chondrocytes and fibroblasts
- Cellular aging model investigations examining senescence-associated markers in vitro
- Extracellular matrix research models focused on structural protein regulation
- Renal and dermal cell culture systems used for comparative peptide studies
All applications described reflect controlled laboratory research contexts and do not imply clinical or therapeutic use.
Cartalax (50mg) Dosing & Observed Effects in Research
Experimental dosing of Cartalax varies by study design and assay type. In vitro research commonly evaluates concentrations between 0.1 and 1.0 μg/mL, with incubation periods adjusted according to theexperimental endpoints.
Historical animal studies from early bioregulator research describe low-microgram dosing over defined timeframes. Contemporary research primarily focuses on in vitro experimental models rather than in vivo administration.
Reported laboratory observations include changes in gene expression profiles, cell proliferation markers, and assay-specific molecular readouts. These findings are derived exclusively from controlled research environments and do not indicate safety, efficacy, or clinical relevance.
Cartalax (50mg) Storage, Safety & References
- Store lyophilized vials at ≤ –20 °C for long-term stability
- Optimal long-term storage at –80 °C
- Keep vials sealed, dry, and protected from light
- Allow vials to equilibrate to room temperature before opening
- Reconstitute only with bacteriostatic water
- Store reconstituted solutions at 2–8 °C, aliquot as needed, and avoid repeated freeze-thaw cycles
- Mix gently to preserve peptide integrity
Dispose of unused material according to institutional laboratory guidelines.
References
https://pubmed.ncbi.nlm.nih.gov/19902107
https://pubmed.ncbi.nlm.nih.gov/27909961
https://pubmed.ncbi.nlm.nih.gov/27259496
https://pubmed.ncbi.nlm.nih.gov/32160428
Compliance Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use.